Category: CBD Stocks
Stocks slump as Wall Street heads for another losing week
NEW YORK (AP) — Stocks slumped on Wall Street Friday, leaving the S&P 500 with its biggest one-day loss in…
CBD Skin Care Market Evolving Technology, Segmentation and Industry Analysis by 2025
The MarketWatch News Department was not involved in the creation of this content. Apr 22, 2022 (Market Insight Reports) —…
InterCure Stock: Under-the-Radar Pot Company Reports Stellar Q4 & Full-Year Results
Undervalued InterCure Ltd Poised for Massive Growth For the most part, cannabis stock investors have their eyes on the U.S….
How CBD biomanufacturing could make Europe change and win the cannabis game
In this special guest post Kevin Chen, Co-founder & CEO, Hyasynth Bio, a precision fermentation startup producing sustainable cannabinoids, and…
Hempu Time innovates CBD- and TCM-contained products with Yunnan Baiyao
BEIJING, April 21, 2022 /PRNewswire/ — This is a news report by China.org.cn about China’s enterprises’ strive to promote traditional Chinese…
Can B Corp. Discusses 2022 Growth Opportunities and New Partnerships on The Stock Day Podcast
(MENAFN– Newsfile Corp) Can B Corp. Discusses 2022 Growth Opportunities and New Partnerships on The Stock Day Podcast Phoenix, Arizona–(Newsfile…
Keoni CBD Announces Acquisition of Blush Wellness Brand
Kentucky’s Premier CBD Company Expands its Female Offerings with Women-Focused Beauty and Wellness Brand Acquisition LOUISVILLE, KY, April 20, 2022…
Kadenwood Inc Brands LEVEL SELECT and Social CBD Reach New Distribution Milestone with Placement in Over 22,000 Retail Locations Nationally
CBD Category Leader Expands Retail Distribution with Products Now Available at leading Drug and Grocery Retailers throughout the US NEWPORT…
5WPR Celebrates Cannabis Awareness Day This 4/20 by Continuing Expansion of CBD and Cannabis PR Team
NEW YORK, April 20, 2022 /PRNewswire/ — In honor of Cannabis Awareness Day, 5WPR, one of the largest independently-owned PR…
Clever Leaves Partners With Biom Therapeutics As Supplier Of Pharmaceutical-Grade CBD Used In Clinical Trials
© Provided by Benzinga Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), announced a two-year supply agreement with American, clinical-stage…
Recent Comments